Artidis Ag
Clinical trials sponsored by Artidis Ag, explained in plain language.
-
Nanomechanical biopsy could revolutionize pancreatic cancer care
Diagnosis Recruiting nowThis study tests a new technology called NEO-Match® that measures the stiffness of pancreatic tissue from a biopsy sample. Researchers want to see if this test can predict how well a patient will respond to cancer treatment and help diagnose pancreatic cancer more accurately. Abo…
Phase: NA • Sponsor: ARTIDIS AG • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New 'Touch' test could spot breast cancer faster than biopsy
Diagnosis Recruiting nowThis study is testing a new device called ARTIDIS that measures how stiff or soft breast tissue is, which may help doctors tell if a lump is cancerous. About 2,700 people with suspicious breast lesions will have their biopsy tissue tested with this device. The goal is to see if i…
Phase: NA • Sponsor: ARTIDIS AG • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC